Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr 7;63(9):1749-1756.
doi: 10.1515/cclm-2024-1312. Print 2025 Aug 26.

Screening primary aldosteronism by plasma aldosterone-to-angiotensin II ratio

Affiliations
Free article

Screening primary aldosteronism by plasma aldosterone-to-angiotensin II ratio

Clara Wai-Shan Lo et al. Clin Chem Lab Med. .
Free article

Abstract

Objectives: Primary aldosteronism (PA) is a common cause of secondary hypertension. The aldosterone-to-renin ratio (ARR) is the current recommended biomarker for PA screening, but it has limitations. This study evaluates another ratio, the aldosterone-to-angiotensin II ratio (AAIIR), as an alternative screening tool for PA.

Methods: Archived plasma samples for ARR from a group of 152 hypertensive patients undergoing PA screening were retrieved for AAIIR analyses. Both AAIIR and ARR were measured by liquid chromatography-mass spectrometry methods. Correlation analysis, sensitivity, specificity, and receiver operating characteristic (ROC) curve analysis were performed to assess the diagnostic performance of AAIIR relative to ARR.

Results: AAIIR showed a strong positive correlation with ARR (r=0.79, p<0.0001). The area under the ROC curve for AAIIR (0.94, 95 % CI: 0.90-0.98) was satisfactory and not significantly different from ARR (0.94, 95 % CI: 0.90-0.97, p=0.877). The optimal cutoff values were 577 (pmol/L)/(µg/L-h) and 60 for ARR and AAIIR, respectively. The sensitivity of AAIIR was slightly higher than ARR (91 vs. 88 %), while the specificity was comparable (85 vs. 86 %).

Conclusions: AAIIR demonstrates a comparable diagnostic performance to ARR for PA screening, with potential advantages in efficiency and reliability. Further large-scale studies are needed to validate its efficacy and establish its role in routine clinical practice.

Keywords: aldosterone-to-angiotensin II ratio; diagnostic performance; primary aldosteronism screening.

PubMed Disclaimer

References

    1. Cohen, JB, Bancos, I, Brown, JM, Sarathy, H, Turcu, AF, Cohen, DL. Primary aldosteronism and the role of mineralocorticoid receptor antagonists for the heart and kidneys. Annu Rev Med 2023;74:217–30. https://doi.org/10.1146/annurev-med-042921-100438 . - DOI
    1. Funder, JW, Carey, RM, Mantero, F, Murad, MH, Reincke, M, Shibata, H, et al.. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2016;101:1889–916. https://doi.org/10.1210/jc.2015-4061 . - DOI
    1. Raizman, JE, Diamandis, EP, Holmes, D, Stowasser, M, Auchus, R, Cavalier, E. A renin-ssance in primary aldosteronism testing: obstacles and opportunities for screening, diagnosis, and management. Clin Chem 2015;61:1022–7. https://doi.org/10.1373/clinchem.2015.242990 . - DOI
    1. Gordon, DB, Sachin, IN. Simultaneous measurement of PRA, PRC and PRR and the relation of renin reaction rate to renin substrate concentration. Clin Exp Hypertens(1978) 1980;2:65–87. https://doi.org/10.3109/10641968009038552 . - DOI
    1. Campbell, DJ, Nussberger, J, Stowasser, M, Danser, AH, Morganti, A, Frandsen, E, et al.. Activity assays and immunoassays for plasma Renin and prorenin: information provided and precautions necessary for accurate measurement. Clin Chem 2009;55:867–77. https://doi.org/10.1373/clinchem.2008.118000 . - DOI

LinkOut - more resources